Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients
Cancer, 04/24/2012
Clinical Article
Won HH et al. – The current results indicated that a genome–wide pharmacogenomic approach is useful for identifying novel polymorphism predictors of severe oxaliplatin–induced chronic peripheral neuropathy (OXCPN) that may be used in personalized chemotherapy.



